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Abstract Identification of Nipah virus (NiV) T-cell-
specific antigen is urgently needed for appropriate diag-
nostic and vaccination. In the present study, prediction and
modeling of T-cell epitopes of Nipah virus antigenic pro-
teins nucleocapsid, phosphoprotein, matrix, fusion, glyco-
protein, L protein, W protein, V protein and C protein
followed by the binding simulation studies of predicted
highest binding scorers with their corresponding MHC
class I alleles were done. Immunoinformatic tool ProPred1
was used to predict the promiscuous MHC class I epitopes
of viral antigenic proteins. The molecular modelings of the
epitopes were done by PEPstr server. And alleles structure
were predicted by MODELLER 9.10. Molecular dynamics
(MD) simulation studies were performed through the
NAMD graphical user interface embedded in visual mole-
cular dynamics. Epitopes VPATNSPEL, NPTAVPFTL and
LLFVFGPNL of Nucleocapsid, V protein and Fusion pro-
tein have considerable binding energy and score with
HLA-B7, HLA-B*2705 and HLA-A2MHC class I allele,
respectively. These three predicted peptides are highly
potential to induce T-cell-mediated immune response and
are expected to be useful in designing epitope-based vac-
cines against Nipah virus after further testing by wet
laboratory studies.
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Introduction
Nipah virus (NiV) was isolated in 1999 and was identified
as the etiological agent responsible for an outbreak of
severe respiratory disease and fatal encephalitis in
Malaysia and Singapore in pigs and humans (Chua et al.
1999). During the first NiV outbreak, the virus infected
both pigs and humans, in addition to a small number of
cats, dogs and horses (Chua et al. 2000; Epstein et al.
2006). NiV, a member of the family Paramyxoviridae,
possesses a negative-sense, non-segmented RNA genome
that is 18,246 nt (Malaysian isolate) or 18,252 nt (Ban-
gladesh isolate) in length (Harcourt et al. 2005). It has six
transcription units that encode six structural proteins, the
nucleocapsid (N), phosphoprotein (P), matrix protein (M),
fusion protein (F), glycoprotein (G) and polymerase (L).
Similar to other paramyxoviruses, the P gene of NiV
expresses four proteins, namely P, V, W and C (Harcourt
et al. 2000; Wang et al. 2001).
In Bangladesh, 135 probable or confirmed cases of
NiV infection in humans were identified from 2001
through 2008; 98 (73 %) were fatal (Luby et al. 2009).
Active Nipah virus encephalitis surveillance identified an
encephalitis cluster and sporadic cases in Faridpur, Ban-
gladesh, in January 2010. 16 case patients were identi-
fied, in which 14 of these patients died (Sazzad et al.
2013).
Vaccination is the most effective of all the medical
interventions to save human and animal lives and to in-
crease production (Horzinek 1999; Tang et al. 2012a).
Compared to the conventional vaccines, peptide- or
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epitope-based vaccines are easy to produce, more speci-
fic, cost effective, less time consuming and also safe
(Kumar et al. 2013). It is well established that T cells
play a critical role in inducing cellular immune response
against foreign antigens but they recognize antigenic
fragments only when they are associated with major
histocompatibility complex (MHC) molecules exposed on
surface of all vertebrate cells (Shekhar et al. 2012; Mo-
habatkar and Mohammadzadegan 2007). Immunoinfor-
matics approach uses computational algorithms to predict
potential vaccine candidates or T-cell epitopes. The ad-
vantage of a peptide- or epitope-based vaccine is the
ability to deliver high doses of the potential immunogen
and at a low cost (Von Hoff et al. 2005; Tang et al.
2012b). Viral protein which could act as a vaccine can-
didate must be surface-exposed, antigenic and responsible
for pathogenicity (Cerdino-Tarraga et al. 2003; Verma
et al. 2011).
Materials and methods
The amino acid sequence of Nucleocapsid, phosphopro-
tein, matrix, fusion, glycoprotein, L protein, W protein, V
protein and C protein was retrieved from the protein
sequence database of NCBI (http://www.ncbi.nlm.nih.
gov/protein) and their accession number is shown in
Table 1.
Prediction of MHC class I binding peptides
The prediction of promiscuous MHC class I binding pep-
tides was done using a popular immunoinformatic tool
ProPred I (Singh and Raghava 2001). It is an online web
tool which uses matrix-based method that allows the pre-
diction of MHC-binding sites in an antigenic sequence for
MHC class I alleles. It also allows the prediction of the
standard proteasome and immunoproteasome cleavage
sites in an antigenic sequence. The simultaneous prediction
of MHC binders and proteasome cleavage sites in an
antigenic sequence leads to the identification of potential
T-cell epitopes.
Structure-based modeling of T-cell epitopes
The PEPstr (peptide tertiary structure prediction server)
server (Kaur et al. 2007) predicts the tertiary structure of
small peptides with sequence length varying between 7 and
25 residues. The prediction strategy is based on the real-
ization that b-turn is an important and consistent feature of
small peptides in addition to regular structures. Thus, the
methods use both the regular secondary structure infor-
mation predicted from PSIPRED and b-turns information
predicted from BetaTurns. The side-chain angles are placed
using standard backbone-dependent rotamer library. The
structure is further refined with energy minimization and
molecular dynamic simulations using Amber version 6.
Table 1 Scores generated by ProPred for MHC class I
Protein Accession no. Length of amino acid Start position Peptides/epitope Allele ProPred score
Nucleocapsid ACT32611 532 38 VPATNSPEL HLA-B7 1200
474 SLLNLRSRL HLA-A2 5968.882
Phosphoprotein ACT32612 709 624 EPYGAAVQL HLA-B*5102 2640
464 NPADDNDSL HLA-B*5102 550
Matrix ACT32613 352 201 IAFNLLVYL HLA-A*0201 4702.218
293 FQKNLCFSL HLA-B*2705 3000
Fusion ACT32614 546 209 LLFVFGPNL HLA-A2 2678.131
192 KQTELSLDL HLA-B*2705 9000
125 AQITAGVAL HLA-B*2705 2000
Glycoprotein ACT32615 602 247 RIIGVGEVL HLA-B*2705 2000
38 EGLLDSKIL HLA-B*5102 4400
45 ILSAFNTVI HLA-A2 3901.211
L protein ACT32616 2244 1688 NPQEKICVL HLA-B*5102 2662
1482 FPLWSTEEL HLA-B*5102 5280
W protein YP_007188592 449 66 DGDVERRNL HLA-B*5101 520
V protein NP_112023 456 186 NPTAVPFTL HLA-B*2705 2000
66 DGDVERRNL HLA-B*5101 520
316 KEEPPQKRL HLA-B*2705 2000
C protein NP_112024 166 116 PDMDLLQAL HLA-B*2705 2000
0 MMASILLTL HLA-B*2705 2000
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Modeling and validation of MHC I alleles
The IMGT/HLA database (http://www.ebi.ac.uk/ipd/imgt/
hla/intro.html) (Robinson et al. 2013) currently contains
10,103 allele sequences. In addition to the physical se-
quences, the database contains detailed information con-
cerning the material from which the sequence was derived
and data on the validation of the sequences. The IMGT/
HLA database allows you to retrieve information upon a
specific HLA allele (http://www.ebi.ac.uk/ipd/imgt/hla/
allele.html) as named in the WHO Nomenclature Com-
mittee Reports. 3D structures of alleles were retrieved from
IMGT/HLA database. Some of the allele’s structures,
which are not presented in IMGT/HLA database, were
modeled with the help of MODELLER 9.10. The stereo-
chemical qualities of the alleles were checked by PRO-
CHECK (Laskowski et al. 1993).
Molecular docking
Docking of peptides and alleles structure was carried out
using AutoDock 4.2 (Goodsell and Olson 1990; Morris
et al. 1998). Gasteiger charges were added to the ligand and
maximum six numbers of active torsion are given to the
lead compound using AutoDock tool (http://autodock.
scripps.edu/resources/adt). Kollaman charges and solva-
tion term were added to the protein structure using Au-
toDock tool. The Grid for docking calculation was centered
to cover the protein-binding site residues and accommodate
ligand to move freely. During the docking procedure, a
Lamarckian genetic algorithm (LGA) was used for flexible
ligand rigid protein docking calculation. Docking pa-
rameters were as follows: 30 docking trials, population size
of 150, maximum number of energy evaluation ranges of
250,000, maximum number of generations is 27,000, mu-
tation rate of 0.02, cross-over rate of 0.8, other docking
parameters were set to the software’s default values.
Molecular dynamics simulation of epitope and HLA
allele complex
Molecular dynamics simulation was done using the NAMD
graphical interface module (James et al. 2005) incorporated
visual molecular dynamics (VMD 1.9.2) (Humphrey et al.
1996). A protein structure file (psf) stores structural in-
formation of the protein, such as various types of bonding
interactions. The psf was created from the initial pdb and
topology files. The psfgen package of VMD is used to
create this. To create a psf, we will first make a pgn file,
which will be the target of psfgen. After running psfgen,
two new files were generated protein pdb and protein psf
and by accessing PSF and PDB files; NAMD generated the
trajectory DCD file. Root mean square deviation (RMSD)
of the complex was completed using rmsd tcl source file
from the Tk console and finally rmsd dat was saved and
accessed in Microsoft office excel 2007.
Results and discussion
Prediction and analysis of MHC class I binding
peptides
The Nucleocapsid peptide VPATNSPEL at position 38–46
showed ProPred score of 1200 with HLA-B7 MHCI allele.
The V protein peptide NPTAVPFTL at position 186–194
showed ProPred score of 2000 with the HLA-B*2705 al-
lele. And the fusion protein peptide LLFVFGPNL at po-
sition 209–217 showed ProPred score of 2678.131 with the
HLA-A2 allele. ProPred scores of peptides with MHC I
alleles are shown in Table 1.
Docking energy determination by AutoDock
3-D coordinate files of allele were obtained through
IMGT/HLA database or model through MODELLER
(Table 2) were validated using PROCHECK tool. After
that, binding simulation studies show that nucleocapsid
epitope VPATNSPEL with HLA-B7 allele, V protein
epitope NPTAVPFTL with HLA-B*2705 allele as well as
fusion epitope LLFVFGPNL with HLA-A2 allele formed
stable HLA–peptide complexes with the energy
minimization values of -5.07, -3.13 and -3.11 kcal/mol,
respectively (Table 3). After docking studies, we deter-
mined the number of H bonds present in the stable com-
plex formed.
Using AutoDock, it was found that three H-bonds were
present in peptide VPATNSPEL-HLA-B7 allele complex
as shown in (Fig. 1), first H-bond formed between allele
residue ASP30:O with epitope amino acid THR4:OG1,
second H-bond formed between allele residue
Table 2 List of class I MHC alleles considered in this study for
prediction of binding peptides
S. no. Allele Template (PDB ID) Crystal structure/model
1 HLA-B7 3VCL Crystal structure
2 HLA-A2 1AKJ Crystal structure
3 HLA-B*5102 1E27 Model
4 HLA-A*0201 1AKJ Crystal structure
5 HLA-B*2705 1HSA Crystal structure
6 HLA-B*5101 1E27 Crystal structure
The table lists the PDB IDs of the template used for prediction and
whether it was a crystal structure or a structural model
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ARG48:NH2 with epitope amino acid GLU8:OE1 and
third H-bond formed between allele residue TYR27:OH
with epitope amino acid ALA3:O, whereas one H-bond
was present in V protein peptide NPTAVPFTL - HLA-
B*2705 allele complex (Fig. 2) via residue ASP29:O with
epitope amino acid ASN1:HN1. Fusion protein peptide
LLFVFGPNL - HLA-A2 allele complex depicting posi-
tion of amino acids along with formation of one H-bond
with allele residue ASP122ASP122:OD2 with epitope
amino acid LEU1:N (Fig. 3).
Molecular dynamics simulation of peptide–allele
complex through NAMD
The peptide–allele complexes formed by AutoDock were
subjected to molecular dynamics simulation and RMSD.
Nucleocapsid epitope VPATNSPEL-HLA-B7 allele com-
plex displayed the highest peak at RMSD value of 1.16 A˚
(Fig. 4). V protein peptide NPTAVPFTL-HLA-B*2705
allele complex resulted in highest peak at RMSD value of
0.46 A˚ (Fig. 5). And epitope LLFVFGPNL-HLA-A2 allele
complex resulted in highest peak at RMSD value of 0.47 A˚
(Fig. 6).
Nipah virus (NiV) was associated with highly lethal
febrile encephalitis in humans and a predominantly respi-
ratory disease in pigs. Periodic deadly outbreaks,
documentation of person-to-person transmission, and the
potential of this virus as an agent of agroterror reinforce the
need for effective means of therapy and prevention (Wal-
pita et al. 2011). The current study incorporates im-
munoinformatics approach for reducing the time consumed
in the long array of experiments to avoid hit and trial sets.
Walpita et al. (2011) describe the vaccine potential of NiV
proteins glycoprotein, fusion and matrix. Sakib et al.
Table 3 Docking result of epitopes with allele structures
Protein Peptide/epitope Allele BE IME IE TorE VdwE EE
Nucleocapsid VPATNSPEL HLA-B7 -5.07 -12.52 -4.06 7.46 -9.47 -3.05
SLLNLRSRL HLA-A2 -1.45 -12.49 -4.94 11.04 -11.75 -0.74
Phosphoprotein EPYGAAVQL HLA-B*5102 -1.27 -9.33 -7.82 8.05 -9.57 0.24
NPADDNDSL HLA-B*5102 -0.65 -9.3 -0.89 8.65 -8.13 -1.16
Matrix IAFNLLVYL HLA-A*0201 -1.98 -11.52 -5.23 9.55 -11.3 -0.22
FQKNLCFSL HLA-B*2705 0.35 -10.39 -4.94 10.74 -8.36 -2.03
Fusion LLFVFGPNL HLA-A2 -3.11 -11.76 -4.98 8.65 -10.47 -1.29
KQTELSLDL HLA-B*2705 2.72 -8.32 -6.03 11.04 -8.14 -0.18
AQITAGVAL HLA-B*2705 -0.64 -8.39 -3.49 7.76 -6.6 -1.8
Glycoprotein RIIGVGEVL HLA-B*2705 0.36 -9.18 -3.76 9.55 -8.49 -0.69
EGLLDSKIL HLA-B*5102 0.05 -10.39 -5.75 10.44 -10.13 -0.26
ILSAFNTVI HLA-A2 -1.04 -9.98 -8.09 8.95 -9.94 -0.05
L protein NPQEKICVL HLA-B*5102 0.55 -10.49 -5.44 11.04 -10.62 0.14
FPLWSTEEL HLA-B*5102 1.31 -8.53 -6.14 9.84 -7.25 -1.28
W protein DGDVERRNL HLA-B*5101 2.58 -8.46 -3.91 11.04 -8.34 -0.12
V protein NPTAVPFTL HLA-B*2705 -3.13 -10.29 -3.5 7.16 -9.31 -0.98
DGDVERRNL HLA-B*5101 2.38 -8.66 -3.8 11.04 -7.75 -0.9
KEEPPQKRL HLA-B*2705 -0.26 -11.59 -4.3 11.34 -8.63 -2.97
C protein PDMDLLQAL HLA-B*2705 1.76 -8.09 -4.61 9.84 -6.07 -2.02
MMASILLTL HLA-B*2705 -2.38 -12.22 -2.54 9.84 -11.46 -0.76
BE binding energy, IME intermolecular energy, IE internal energy, TorE torsional energy, VdwE Vdw-lbDesolv energy, EE electrostatic energy
Fig. 1 Docked nucleocapsid protein peptide VPATNSPEL-HLA-B7
allele complex depicting position of amino acids along with the
formation of 3 H bonds with ASP30, TYR27 and ARG48
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(2014) designed epitope-based peptides for the utility of
vaccine development by targeting glycoprotein G and en-
velope protein F of Nipah virus (NiV) that, respectively,
facilitates attachment and fusion of NiV with host cells.
AutoDock resulted in good binding affinity along with H
bonds at default parameters. The molecular dynamics
simulation showed that complex formed between a peptide
and allele was attaining proper stability by creating a
parallelism in RMSD over a time window. The mentioned
peptides can be either isolated or formulated for further
in vitro and in vivo testings.
Conclusion
The conclusion drawn from the present study is that the
three epitopes VPATNSPEL, NPTAVPFTL and
LLFVFGPNL of nucleocapsid, V protein and fusion pro-
tein, respectively, have considerable binding with HLA-
B7, HLA-B*2705 and HLA-A2MHC class I allele and
low-energy minimization values providing stability to the
peptide–MHC complex. These peptide constructs may
further be undergone wet laboratory studies for the devel-
opment of targeted vaccine against Nipah virus.
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Fig. 2 Docked V protein peptide NPTAVPFTL–HLA-B*2705 allele
complex depicting position of amino acids along with the formation
of 1 H bond with ASP29
Fig. 3 Docked fusion protein peptide LLFVFGPNL–HLA-A2 allele
complex depicting position of amino acids along with the formation
of 1 H bond with ASP122
Fig. 4 Graph displaying molecular dynamic simulation of Nu-
cleocapsid peptide–allele complex, resulted in highest peak at 1.16 A˚
Fig. 5 Graph displaying molecular dynamic simulation of V protein
peptide–allele complex, resulted in highest peak at 0.46 A˚
Fig. 6 Graph displaying molecular dynamic simulation of fusion
protein peptide–allele complex, resulted in highest peak at 0.47 A˚
3 Biotech (2015) 5:877–882 881
123
Conflict of interest The authors have no conflict of interest re-
garding the publication of this paper.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Cerdino-Tarraga AM, Efstratiou A, Dover LG, Holden MTG, Pallen
M et al (2003) The complete genome sequence and analysis of
Corynebacterium diphtheria NCTC13129. Nucl Acids Res
31:6516–6523
Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek
TG, Zaki SR, Paul G, Lam SK, Tan CT (1999) Fatal encephalitis
due to Nipah virus among pig-farmers in Malaysia. Lancet
354:1257–1259
Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A et al (2000)
Nipah virus: a recently emergent deadly paramyxovirus. Science
288:1432–1435
Epstein JH, Abdul Rahman S, Zambriski JA, Halpin K, Meehan G
et al (2006) Feral cats and risk for Nipah virus transmission.
Emerg Infect Dis 12:1178–1179
Goodsell DS, Olson AJ (1990) Automated docking of substrates to
proteins by simulated annealing. Proteins 8(3):195–202
Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ et al
(2000) Molecular characterization of Nipah virus, a newly
emergent paramyxovirus. Virology 271:334–349
Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B et al (2005)
Genetic characterization of Nipah virus, Bangladesh, 2004.
Emerg Infect Dis 11:1594–1597
Horzinek MC (1999) Vaccination: a philosophical view. Adv Vet
Med 41:1–6
Humphrey W, Dalke A, Schulten K (1996) VMD-visual molecular
dynamics. J Mol Gr 14:33–38
James CP, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E,
Chipot C, Skeel RD, Kale L, Schulten K (2005) Scalable
molecular dynamics with NAMD. J Comput Chem
26:1781–1802
Kaur H, Garg A, Raghava GPS (2007) PEPstr: a de novo method for
tertiary structure prediction of small bioactive peptides. Protein
PeptLett 14:626–630
Kumar A, Jain A, Shraddha Verma SK (2013) Screening and
structure-based modeling of T-cell epitopes of Marburg virus
NP, GP and VP40: an immunoinformatic approach for designing
peptide-based vaccine. Trends Bioinform 6:10–16
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993)
PROCHECK—a program to check the stereochemical quality of
protein structures. J App Cryst 26:283–291
Luby SP, Gurley ES, Hossain MJ (2009) Transmission of human
infection with Nipah virus. Clin Infect Dis 49:1743–1748
Mohabatkar H, Mohammadzadegan R (2007) Computational com-
parison of T-cell epitopes of gp120 of Iranian HIV-1 with
different subtypes of the virus. Pak J Biol Sci 10:4295–4298
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK,
Olson AJ (1998) Automated Docking using a Lamarckian
genetic algorithm and empirical binding free energy function.
J Comput Chem 19:1639–1662
Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh
SGE (2013) The IMGT/HLA Database. Nucleic Acids Res
41:D1222–D1227
Sakib MS, Md. Islam R, MahbubHasan AKM, NurunNabi AHM
(2014) Prediction of epitope-based peptides for the utility of
vaccine development from fusion and glycoprotein of Nipah
virus using in silico approach. Adv Bioinform, Article ID
402492, p 17
Sazzad HMS, Hossain MJ, Gurley ES, Ameen KMH, Parveen S,
Islam MS et al (2013) Nipah virus infection outbreak with
nosocomial and corpse-to-human transmission, Bangladesh.
Emerg Infect Dis 19(2):210 (Internet)
Shekhar C, Dev K, Verma SK, Kumar A (2012) In-silico: screening
and modeling of CTL binding epitopes of crimeancongo
hemorrhagic fever virus. Trends Bioinform 5:14–24
Singh H, Raghava GPS (2001) ProPred: prediction of HLA-DR
binding sites. Bioinformatics 17(12):1236–1237
Tang H, Liu XS, Fang YZ, Pan L, Zhang ZW et al (2012a) The
epitopes of foot and mouth disease. Asian J Anim Vet Adv
7:1261–1265
Tang H, Liu XS, Fang YZ, Pan L, Zhang ZW et al (2012b) Advances
in studies on vaccines of foot-and-mouth disease. Asian J Anim
Vet Adv 7:1245–1254
Verma SK, Yadav SSP, Kumar A (2011) In silico T-cell antigenic
determinants from proteome of H1N2 swine influenza A virus.
Online J Bioinform 12:371–378
Von Hoff DD, Evans DB, Hruban RH (eds) (2005) Pancreatic cancer.
Jones and Bartlett, Sudbury
Walpita P, Barr J, Sherman M, Basler CF, Wang L (2011) Vaccine
potential of Nipah virus-like particles. PLoS One 6(4):e18437
Wang L, Harcourt BH, Yu M, Tamin A, Rota PA et al (2001)
Molecular biology of Hendra and Nipah viruses. Microbes Infect
3:279–287
882 3 Biotech (2015) 5:877–882
123
